Brief: Altimmune Announces Proposed Underwritten Public Offering Of Securities
22/04/2026 23:02
April 22 (Reuters) - Altimmune Inc ALT.O: ALTIMMUNE ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF SECURITIES ALTIMMUNE INC - NET PROCEEDS TO FUND PHASE 3 MASH TRIAL AND GENERAL PURPOSES Source text: ID:nGNX35rcG5 Further company coverage: ALT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altimmune
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial (updated)